Advanced Medicine

Researchers are investigating the therapeutic value of immunotherapies for treating infectious diseases.

A gene therapy could help prevent the symptoms of glaucoma.

A repurposed drug could help improve immunotherapy response rates.

We must collaborate to address stability challenges in viral vector manufacturing.

Intel shows a rise in cell and gene therapy development in the US, with China not far behind.

Tackling solid tumors with macrophages, a stem cell cure for HIV, and travel bans… What’s new in advanced medicine?

In what may have been one of the last advanced therapy meetings to go ahead for some time, delegates met in London in late February for CAR-TCR.

How can manufacturing be improved for viral vectors?

Sitting Down With… Mike McMullen, President and CEO, Agilent Technologies, Santa Clara, California, USA.

Claudia Zylberberg explains the importance of ancillary material quality for advancing cell and gene therapies.